Texas Oncology Sugar Land and Oncology Today
Last Modified: September 14, 2007
Conference Dates: October 20, 2007
Conference Location: Houston, Texas
Sponsoring Group: Texas Oncology Sugar Land and Oncology Today
Conference Web Page URL: http://www.lungcancer2007.com
Topics Covered: The CME/CE accredited program, Lung Cancer Care in 2007: A Multidisciplinary Approach, offers a unique opportunity for community-based oncologists and other cancer care providers to rapidly acquire knowledge of the most recent advances in non-small cell lung cancer treatment. A diverse group of community and academic lung cancer experts will discuss the immediate integration of novel treatments into the community setting. Participants will take away practical information to assist in delivering the most effective cancer-fighting strategies for their patients.
Conference Objectives: Learning Objectives
Who Should Attend: This continuing medical education program is intended for community-based medical, surgical, and radiation oncologists; thoracic surgeons; pulmonologists; and fellows. Primary care physicians, nurses, pharmacists, and midlevel practitioners involved in the care of lung cancer patients are also encouraged to attend.
Conference Agenda: Program Agenda (8:00AM – 3:00PM)
Treatment for Early Stage Lung Cancer
Registration Information: Visit www.lungcancer2007.com or for additional course information, please call Dawn Riggenbach at (281) 423-2683 or Dawn.Riggenbach@USOncology.com.
Conference Fees: FREE
Continuing Education: No
Miscellany: Program Faculty: Program Chairperson and Moderator
Sep 27, 2011 - For patients with early-stage breast cancer, the addition of zoledronic acid to standard adjuvant therapy does not offer any benefit for disease-free or overall survival, according to a study published in the New England Journal of Medicine to coincide with presentation at the 2011 European Multidisciplinary Cancer Congress, held from Sept. 23 to 27 in Stockholm, Sweden.